Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
6.10
-2.43 (-28.49%)
Jun 1, 2026, 1:53 PM EDT - Market open

Co-Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-48.5-46.9-37.64-35.33-14.2436.66
Depreciation & Amortization
1.081.111.381.231.280.34
Stock-Based Compensation
1.592.255.438.347.545.51
Other Adjustments
-0.4217.57-1.08-1.965.791.47
Change in Receivables
0.08-0.030.192.5414.92-8.74
Changes in Inventories
0.280.130.270.41-3.675.71
Changes in Accounts Payable
-0.92-3.112.161.77-2.48-0.3
Changes in Income Taxes Payable
-0.73-0.710.05-0.52-2.22.64
Changes in Unearned Revenue
-0.04-0.03-0.320.36-0.15-0.16
Changes in Other Operating Activities
0.380.590.411.08-0.22-2.05
Operating Cash Flow
-28.24-29.14-29.16-22.086.5741.08
Operating Cash Flow Growth
-----84.01%45.86%
Capital Expenditures
-0.75-0.7-0.75-1.37-1.43-0.67
Purchases of Investments
-0.15-6.59-40.8-110.5-68-
Proceeds from Sale of Investments
19.7733.6758.77127.2511.263.08
Payments for Business Acquisitions
-----1.2
Other Investing Activities
-0.1-0.1-0.14--0.49
Investing Cash Flow
18.7726.2717.0715.39-58.174.1
Issuance of Common Stock
12.2511.810.1-0.180.45
Repurchase of Common Stock
----1.36-14.21-
Net Common Stock Issued (Repurchased)
12.2511.810.1-1.36-14.030.45
Financing Cash Flow
15.7911.810.1-1.36-14.030.45
Net Cash Flow
6.338.95-11.98-8.06-65.6345.63
Free Cash Flow
-28.99-29.84-29.9-23.455.1440.41
Free Cash Flow Growth
-----87.28%47.54%
FCF Margin
-4036.41%-4793.17%-763.79%-344.20%15.02%41.28%
Free Cash Flow Per Share
-17.83-22.43-29.57-23.974.9040.54
Levered Free Cash Flow
-49.19-49.62-34.44-32.36-23.1242.17
Unlevered Free Cash Flow
-49.86-51.22-36.95-36.62-29.2642.51